Early Prostate Cancer Kept at Bay in Two Studies for High-Risk Men - Bloomberg

Bloomberg

Early Prostate Cancer Kept at Bay in Two Studies for High-Risk Men Bloomberg Men with an early form of prostate cancer who are at high risk of seeing it spread and turn deadly may benefit from treatment with Johnson & Johnson and Pfizer Inc. drugs that slow progression of the disease. J&J's experimental medicine apalutamide and ... Apalutamide Delays Metastasis in Prostate CancerCancer Network Pfizer's Xtandi delays prostate cancer spread in early stage diseaseReuters Prostate cancer survivors call for greater research and urge men over-50 to get themselves checkedThe Courier UroToday -The Australian Financial Review -Deccan Chronicle -The Australian all 33 news articles »

from Health - Google News http://ift.tt/2Env4WQ